Navigation Links
Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
Date:11/7/2007

SWIFTWATER, Pa., and LYON, France, Nov. 7 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has initiated Phase II testing of its cell culture-based seasonal influenza vaccine in the U.S.

The initiation of Phase I was announced on Sept 25, 2006. This project is part of a contract awarded in 2005 by the U.S. Department of Health and Human Services (HHS) aimed at accelerating the development of a new cell culture- based influenza vaccine. Phase II trials involving healthy adult volunteers in the U.S. will focus further on the safety profile and immunogenicity of the cell-based vaccine.

This vaccine was developed using the PER.C6(R) cell line, licensed from Dutch biotechnology company, Crucell N.V. PER.C6 Cell technology offers Sanofi Pasteur a promising and reliable production method for seasonal and pandemic influenza vaccines in addition to traditional, proven egg-based production. The production scale potential of the PER.C6 cell line has been demonstrated in a successful bioreactor run of 20,000 liters, suggesting robustness of PER.C6 technology and further showing that this may be a suitable cell line for large-scale manufacturing of its influenza vaccine. This scale-up process was achieved under a subcontracting agreement between Sanofi Pasteur and Lonza Biologics plc (Lonza Group).

As the world leader in the research, development and manufacture of influenza vaccines, Sanofi Pasteur is actively involved in other projects in the U.S. and Europe with the goal of developing new influenza vaccines.

Seasonal Influenza Overview

Influenza is a highly infectious virus that spreads easily from person to person, primarily when an infected individual coughs or sneezes. According to the World Health Organization (WHO), 5-15% of the population is affected with upper respiratory tract infections in annual influenza epidemics. Hospitalization and deaths mainly occur in high-ris
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
4. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
8. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
9. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. Prolexys Pharmaceuticals Initiates Phase 1 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Healthcare providers ... enterprise content management (ECM) solution, for ... Information System .  These organizations identified enterprise ... and will use OnBase to optimize their ... (Logo:  http://photos.prnewswire.com/prnh/20090130/65710LOGO  ) ...
(Date:5/22/2013)... , May 22, 2013 STEPh, Inc., ... announce the launch of their web site ( ... Reports].  About STEPh Reports ... development.  Each STEPh Report assesses the ... data, projected launch year, company, and specific key issues.  ...
(Date:5/22/2013)... Ohio , May 22, 2013   Life ... health screening services announced today the creation of a ... (MCM) . MCM is a population ... to MCM,s growing list of clients. These important expanded ... costly chronic conditions earlier. Effective prevention reduces cost of ...
Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
... DAYTON, Ohio, Dec. 15 Robbins & Myers, Inc. (NYSE: ... its fiscal 2010 first quarter ending November 30, 2009, before the ... webcast is scheduled for Wednesday, January 6, 2010, at 2:30 ... Officer, and Christopher M. Hix, Vice President and Chief Financial Officer, ...
... , ST. LOUIS, Dec. 15 KV Pharmaceutical ... the Company received a written notice (the "Notice") executed by ... of the Company, requesting that the Board of Directors of ... action by written consent relating to the proposed appointment of ...
Cached Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7
(Date:5/22/2013)... 22, 2013 Phelps Memorial Hospital Center ... Westchester Lung Nodule Center for individuals who would like ... care. Lung cancer is the deadliest form of cancer for ... the U.S. die from lung cancer than from breast, colon ... early detection increases survival rates. It is well established ...
(Date:5/22/2013)... 22, 2013 Hurricane preparation isn’t just ... That’s why Amica Insurance is reminding everyone ... upcoming hurricane season. , “An important part of hurricane ... a senior assistant vice president at Amica Insurance. “The ... the threat of a storm.” , Flood damage is ...
(Date:5/22/2013)... Daytona Beach, FL (PRWEB) May 22, 2013 ... have signed on as a sponsor for this weekend's I ... will take place at 8:00 am at Cocoa Riverside Park ... the community through the I Talk to Strangers social movement. ... team of runners and walkers to participate in the event. ...
(Date:5/22/2013)... HR Strategies recently participated in the Gwinnett Relay ... on Friday May 10, 2013. For never having participated ... over $6,300 for cancer research. , HR Strategies ... first $3,000 for Bronze Level Sponsorship. HR Strategies CEO, ... match the company’s contribution of $3,000; and after just ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Unknown to the ... area at 30 mph. Minutes before it struck, the ... the nearing threat. This gave them time to reach safety ... Data is proud to provide a product that will ... A Wheelock SAFEPATH® SP40S Emergency Evacuation System provides ...
Breaking Medicine News(10 mins):Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:Space Girl Organics to Sponsor May 25 Miracle Run/Walk 2Health News:HR Strategies Raises Over $6,300 for Cancer Research via Relay For Life 2Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2
... devastating neurodegenerative disorders such as Huntington,s disease has been ... the use of cutting-edge genetic techniques. Led by ... Lisbon (led by Dr Tiago Outeiro) and University of ... collaborated to generate novel approaches for tackling the diseases. ...
... January 10, 2011 -- While most blood tests require shipping ... several days for the results, a new device invented by a ... uses just a pinprick of blood in a portable device that ... a big step in point-of-care diagnostics, where testing can be performed ...
... Steven Reinberg HealthDay Reporter , FRIDAY, Jan. 7 ... amount of fluoride in the nation,s drinking water should now ... is a significant help in preventing cavities and tooth decay, ... teeth. About two out of five teens have white spots ...
... Jenifer Goodwin HealthDay Reporter , FRIDAY, Jan. 7 (HealthDay ... skin come to mind, but new research finds that skin isn,t ... facial bones, which lose volume and recede, making you look even ... the bones of the eye socket gradually widen, the brow bone ...
... 2011) Just 5 percent of Parkinson,s disease cases can ... known cause. But a new discovery by researchers at The ... to explain why the vast majority of Parkinson,s patients develop ... Journal of Neuroscience , the researchers demystified a process that ...
... on information to predict their future health, and may be ... a national survey conducted by researchers at Tufts Medical Center, ... hypothetical predictive test to find out if they will later ... average, respondents were willing to pay $300 to $600, depending ...
Cached Medicine News:Health News:New hope in fight against Huntington's disease 2Health News:Engineering team invents lab-on-a-chip for fast, inexpensive blood tests 2Health News:U.S. Officials Recommend Reduced Fluoride Levels in Water 2Health News:Age Takes Toll on Facial Bones, Study Finds 2Health News:Age Takes Toll on Facial Bones, Study Finds 3Health News:Scientists shed light on what causes brain cell death in Parkinson's patients 2Health News:Most consumers want predictive tests to learn if a disease is in their future 2Health News:Most consumers want predictive tests to learn if a disease is in their future 3
Tips are sharp on both sides to puncture, cut and tear the capsule...
... is designed to automatically measure and display ... with heart rate. It's a Blood Pressure ... ergometer and pharmacological stress test environments. Tango ... environments., ,Tango excels where other BP ...
...
... Tamp is an orthopedic balloon designed to ... Like an angioplasty balloon, it can be ... is inflated with radiopaque contrast medium. The ... volume. The force of balloon growth compacts ...
Medicine Products: